GALMED PHARMACEUTICALS LTD. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b958b57d-442b-4941-b62d-4cc0edcf5e7b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-10.3M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-014182 |
| FY 2024 | $-7.5M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-002362 |
| FY 2023 | $-6.9M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-013203 |
| FY 2022 | $-17.9M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009478 |
| FY 2021 | $-32.5M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-011729 |
| FY 2020 | $-28.8M | 2020-01-01 – 2020-12-31 | evidence 0001493152-22-011729 |
| FY 2019 | $-20.5M | 2019-01-01 – 2019-12-31 | evidence 0001493152-22-011729 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GALMED PHARMACEUTICALS LTD. — all facts · Revenue · Operating Income